Amnon Hoffman
11Patents
2h-index
23Co-inventors
54Inventor score
Filing activity: May 17, 1999 → Sep 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6685962B2 | Gastroretentive controlled release pharmaceutical dosage forms | Human Necessities | 76 | Expired |
| US6399086B1 | Pharmaceutical preparations for the controlled release of beta-lactam antibiotics | Human Necessities | 30 | Expired |
| US8658603B2 | Compositions and methods for inducing an immune response | Human Necessities | 2 | Active |
| US10662225B2 | Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88) | Human Necessities | 0 | Active |
| US11052043B2 | Sustained-release injectable formulation | Human Necessities | 0 | Active |
| US11965041B2 | N-methylated cyclic peptides and their prodrugs | Human Necessities | 0 | Active |
| US11261215B2 | Somatostatin prodrugs | Human Necessities | 0 | Active |
| US9725484B2 | Methods and compositions for the treatment of bone remodeling disorders | Human Necessities | 0 | Active |
| US12161763B2 | Formulation and method for increasing oral bioavailability of drugs | Human Necessities | 0 | Active |
| US8993544B2 | Carbamoylphosphonates as inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9555086B2 | Compositions and methods for inducing an immune response | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.